Back to catalogue
№ 285 20 filings · 2021-09-29 → 2026-06-18

MANX FINANCIAL GROUP PLC

MFX
Financial Services Share price 21.50p Market cap £27m Overall fit 250 /1000

Cheap and reasonably solid, but a tiny AIM SME lender is essentially outside the AI-receiver thesis (June 2026 AI RNS is an internal-adoption story, not a beneficiary story), operating leverage is moderate at best, and governance/related-party features cap downside protection.

Fair value range 28p–36p Mid case · £38m
Absolute upside +42.5% vs current market cap
Conviction 3/5 confidence in undervalued call
Supports the call
  • Audited FY accounts with clear segmental disclosure
  • P/E, NAV and tangible book approaches converge on 28-36p
  • Consistent pre-guidance track record
Limits the call
  • Complex 13-subsidiary group with related-party funding
  • Motor-finance FCA compensation scheme liability is not yet quantifiable
Methodology

Blended P/E and NAV multiples vs specialty-finance peers

In one line · bull case

Small, profitable UK/IoM specialty lender at 4x earnings and 0.75x book, with PAL and CAM Wealth extending the growth runway.

In one line · biggest risk

A larger-than-expected FCA motor-finance compensation liability, combined with Stage 3 loan deterioration, could compress the earnings that anchor the valuation.

Drivers
AI beneficiary 15 /100
SME lender that spends on AI internally; no revenue line or addressable-market expansion is captured by MFX itself.
Operating leverage 50 /100
Bank fixed costs give some leverage but commission and personnel costs scale with volume, so uplift is moderate.
Earnings vs expectations 65 /100
Pre-guidance is conservative and consistently delivered; no profit warnings in the 5-year window.
Growth momentum 70 /100
PBT compounded ~50% p.a. 2020-2024; loan book +£210m over 4 years; PAL and CAM Wealth extend runway.
Moat 30 /100
Isle of Man deposit franchise and dual IoM/UK licences are useful but niche; introducer-driven UK lending is competitive.
Earnings quality 55 /100
Cash-generative core but reliant on Stage 3 collateral recovery and periodic impairment reversals.
Management quality 55 /100
Long-serving Executive Chair (Jim Mellon), dividend policy re-established, but related-party lending is a governance flag.
Cyclicality 60 /100
Consumer/SME credit is cyclical; Stage 3 book already 10.6% of gross loans in a soft cycle.
Leverage 55 /100
Balance-sheet gearing is bank-normal; related-party loan notes and convertibles add capital-structure complexity.
Value-trap signals · 7
  • Persistent discount to NAV
  • Related-party loan notes from executive-chair-owned vehicles
  • Complex 13-subsidiary group structure with multiple regulators
  • Convertibles struck at 8-9p vs 34p NAV (dilution overhang on re-rating)
  • Stage 3 gross loans 10.6% of book
  • Scrip dividends signalling capital conservation
  • AIM listing with limited daily liquidity

I'll produce the research note and structured JSON below.

MANX FINANCIAL GROUP PLC (MFX) — Investment Research Note

Executive summary

Manx Financial Group is a small, diversified UK/Isle of Man SME-lending and financial services group whose principal engine is Conister Bank (asset finance, personal loans, point-of-sale automotive finance via PAL, block discounting, structured wholesale funding), supported by FX advisory (MFX Ltd), IoM wealth (Edgewater), UK wealth (CAM Wealth) and a small ventures portfolio (Manx Ventures). Across 2020–2025 the group has compounded PBT from ~£2.0m (2020) to £9.9m (2024) with H1 2025 PBT +16% at £4.1m 2024-03 FY, 2025-09 H1, driven by loan-book growth from ~£179m to ~£393m and a stronger deposit franchise. The single most important valuation point today is that MFX trades at roughly 3–4x trailing earnings and a ~25% discount to tangible-adjusted NAV despite three consecutive record years and a robust CET1 ratio of 12.2%.

Fair value estimate

  • Methodology: blended NAV / P/E (small UK specialist-lender comps trade 5–7x forward earnings and 0.7–1.0x TNAV).
  • Inputs:
    • Reported equity attributable to owners at 30 Jun 2025: £41.2m 2025-09 H1. Shares in issue: 119.7m → NAV ≈ 34p/share. Goodwill/intangibles = £16.3m; tangible book ≈ £24.9m ≈ 21p/share.
    • Annualised H1 2025 earnings to owners: £3.73m × 2 ≈ £7.5m; FY24 owners' earnings £8.1m (basic EPS 6.87p, diluted 5.39p).
    • Applying 4.5–6.0x diluted TTM EPS (~6.2p) → 28–37p; applying 0.9–1.1x reported NAV → 31–38p; anchoring on a tangible book floor of 21p.
  • Fair value range: 28p – 36p per share → implied market cap £33.5m – £43.2m.
  • Mid-point: ~32p / £38.3m.
  • vs current mcap £31.4m (25.5p): absolute upside ~+25% to mid, range −5% to +45% (i.e. asymmetric to the upside from here).

Sector context

  • ICB classification (Financials / Financial Services) is confirmed; MFX is a specialty finance / challenger bank hybrid rather than a mainstream bank.
  • Quality profile: below-average scale, above-average yield (net yield 7.6% at H1 25 2025-09 H1), moderate credit quality (Stage 3 gross £43.8m = 10.6% of gross loans — high for a bank), average leverage, modest but improving profitability (ROE ~19% on FY24 owners' profit / average equity).
  • Listed peers: Arbuthnot Banking Group (ARBB), S&U plc (SUS), Distribution Finance Capital (DFCH); PAL-type point-of-sale credit peers include Vanquis (VANQ).

Investment thesis (3 bullets)

  • Deep-value bank at ~4x earnings with 25% discount to book. FY24 owners' EPS 6.87p, H1'25 owners' EPS 3.11p (basic) — annualised >6p vs 25.5p share price. Even a re-rating to 0.9× book gets you back to 30p 2025-09 H1, 2024-03 FY.
  • Payment Assist consolidation is materially accretive. Since acquiring the remaining 49.9% for £5m in Sep 2024 (avoiding £4m of forecast dividend leakage), PAL — 1,000,000+ unique customers, 7,000+ garages, £97.6m advances at H1 25 — now fully consolidates and provides a distribution channel for CAM Wealth (Jan 2025 acquisition) into UK retail SME 2024-09 PAL acq, 2025-01 CAM Wealth acq, 2025-09 H1.
  • Franchise diversification limits single-line risk: Conister Bank (loan book £383m, LDR 94%), Manx Ventures (13-company portfolio, £16.1m NAV), MFX FX advisory (£0.5m H1 profit), Edgewater and CAM Wealth combine into a resilient earnings mix; deposit efficiency improving with LDR up to 96.6% 2025-09 H1.

Key risks (3 bullets)

  • Stage 3 concentration. Gross Stage 3 loans of £43.8m / 10.6% of gross book with £20.1m allowance — one bad UK vintage could wipe out a year of profit. Impairment charge H1'25 £2.5m 2025-09 H1.
  • Related-party funding and complex capital stack. £6.75m of loan notes from directors/executive chair-owned entities (Jim Mellon, Burnbrae, Culminant); scrip dividends and convertibles suggest capital constraint. Governance is director-heavy 2025-09 H1 Note 14.
  • UK motor-finance / FCA discretionary-commission overhang. Provision of only £202k held; FCA to consult on industry-wide scheme in 2026; scale of eventual liability is not yet knowable 2025-09 H1 Note 21.

Operating leverage

Banks are archetypally high-fixed-cost / high-operating-leverage businesses, but MFX's leverage is diluted by (i) heavy commission/introducer costs (£3.1m of fee expense H1 25) and (ii) rising personnel costs as the group scales into the UK branch deposit-taking licence. H1 25 operating costs (personnel + other + D&A) were £11.9m on operating income of £18.4m — a cost/income ratio of ~65%. Incremental revenue at current scale would drop to profit at broadly the NIM (~62% of interest revenue) less credit cost (0.6-0.8%) less commission (~14% of trading income); a 15% loan-book uplift ceteris paribus would push PBT toward £11–12m (roughly +25–30% vs FY24 annualised), so operating leverage is moderate rather than pure-software-style — call it "50–55" on the 0-100 scale. Manx Ventures and MFX FX are the only truly capital-light, scale-economic pockets 2025-09 H1, 2024-03 FY.

Value-trap signals

  • Persistent trading discount to NAV (management repeatedly flags "45% discount to NAV" 2024-09 H1, now narrower but still ~25%).
  • Complex group structure (13+ operating subsidiaries, multiple regulators, IoM parent).
  • Related-party loan notes from the Executive Chair-owned vehicles funding growth.
  • Convertibles at deep discount to book (conversion prices of 8–9p vs ~34p NAV) — historically dilutive if the price re-rates.
  • Stage 3 loans 10.6% of gross book, well above typical UK bank levels.
  • AIM-listed with modest daily liquidity; scrip dividends indicate desire to conserve cash.

Earnings vs. expectations

Management issues advance-guidance RNS notices ahead of results rather than sell-side consensus. In both 2024 and 2025 the group pre-announced a "16% increase in PBT" and then delivered exactly that (£3.5m in H1'24 and £4.1m in H1'25) 2025-09 advance guidance, 2025-09 H1, 2024-09 H1. FY23 delivered PBT £7.0m vs the H1'23 read-across of £3.0m × 2 = £6.0m (i.e. a beat driven by strong H2). Pattern is one of conservative pre-guidance and consistent in-line-to-modest-beat delivery — no visible profit warnings across the 5-year window.

Conviction

Conviction: 3 (moderate).

  • Anchors: audited FY financials with clear disaggregation; multiple valuation methods (P/E, NAV, tangible book) converge inside a narrow 28–36p band; management guidance track record is honest.
  • Caveats: complex 13-subsidiary group; PAL fair value / earnings sustainability post-consolidation is not yet observable across a full cycle; motor-finance FCA liability is not quantifiable; low free-float and AIM listing make the equity mark subject to non-fundamental drift.
Filings consulted · 25

Every document the LLM read for this note. Click any row to open the source.

  1. 2026-06-18Result OF Agm Amp Dividend Declaration2026-06-18_9626059_result-of-agm-amp-dividend-declaration.md0.30
  2. 2026-06-18Building Opportunity With AI Strategic Update2026-06-18_9626061_building-opportunity-with-ai-strategic-update.md0.95
  3. 2026-05-22Notice OF Agm2026-05-22_9581344_notice-of-agm.md0.30
  4. 2025-10-03Publication OF 2025 Interim Results Presentation2025-10-03_9147852_publication-of-2025-interim-results-presentation.md0.77
  5. 2025-09-22Interim Results For The 6 Months TO 30 June 20252025-09-22_9121623_interim-results-for-the-6-months-to-30-june-2025.md0.77
  6. 2025-09-16Result OF Agm Amp Dividend Declaration2025-09-16_9111336_result-of-agm-amp-dividend-declaration.md0.26
  7. 2025-09-162025 Interim Results Advance Guidance2025-09-16_9111381_2025-interim-results-advance-guidance.md0.77
  8. 2025-08-20Notice OF Agm2025-08-20_9064621_notice-of-agm.md0.20
  9. 2025-01-22Acquisition OF Cam Wealth Group Holdings Limited2025-01-22_8699580_acquisition-of-cam-wealth-group-holdings-limited.md0.49
  10. 2024-10-232024 Interim Results Edison Group Review2024-10-23_8502656_2024-interim-results-edison-group-review.md0.58
  11. 2024-09-24Interim Results For The 6 Months TO 30 June 20242024-09-24_8434206_interim-results-for-the-6-months-to-30-june-2024.md0.58
  12. 2024-09-16Acquisition OF The Remaining 49 9 Interest OF Pal2024-09-16_8417228_acquisition-of-the-remaining-49-9-interest-of-pal.md0.49
  13. 2024-04-25Result OF Agm Amp Dividend Declaration2024-04-25_8157718_result-of-agm-amp-dividend-declaration.md0.14
  14. 2024-04-02Notice OF Agm2024-04-02_8114651_notice-of-agm.md0.14
  15. 2024-03-26Final Results2024-03-26_8106122_final-results.md0.45
  16. 2023-09-21Unaudited Interim Results TO 30 June 20232023-09-21_7768477_unaudited-interim-results-to-30-june-2023.md0.41
  17. 2023-05-30Result OF Agm And Dividend Declaration2023-05-30_7550725_result-of-agm-and-dividend-declaration.md0.07
  18. 2023-05-05Notice OF Agm2023-05-05_7514294_notice-of-agm.md0.07
  19. 2023-03-21Final Results2023-03-21_7479791_final-results.md0.25
  20. 2022-09-27Interim Results For The 6 Months TO 30 June 20222022-09-27_7122807_interim-results-for-the-6-months-to-30-june-2022.md0.23
  21. 2022-09-21Acquisition OF 50 1 Interest IN Payment Assist2022-09-21_7415026_acquisition-of-50-1-interest-in-payment-assist.md0.19
  22. 2022-05-25Result OF Agm Amp Dividend Declaration2022-05-25_7026260_result-of-agm-amp-dividend-declaration.md0.07
  23. 2022-05-16Conditional Acquisition OF 50 1 Interest IN Pal2022-05-16_6890796_conditional-acquisition-of-50-1-interest-in-pal.md0.19
  24. 2021-10-11Acquisition OF Additional 60 Shareholding IN Blx2021-10-11_6759267_acquisition-of-additional-60-shareholding-in-blx.md0.19
  25. 2021-09-29Unaudited Interim Results TO 30 June 20212021-09-29_6597303_unaudited-interim-results-to-30-june-2021.md0.23

This research note was authored by a large language model after reading 20 regulatory filings published between 2021-09-29 and 2026-06-18. Each citation refers to a specific RNS announcement in the underlying data set. The note is an opinion, not advice. Do your own work before risking capital.